Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 345

Results For "UST"

3932 News Found

Dr. Reddy's launches Ephedrine Sulfate injection in the US
Drug Approval | November 01, 2021

Dr. Reddy's launches Ephedrine Sulfate injection in the US

The Akovaz brand and generic market had U.S. sales of approximately US $ 67.5 million MAT for the most recent twelve months ending in August 2021


Glamyo Health widens its dental treatment portfolio
Startup | November 01, 2021

Glamyo Health widens its dental treatment portfolio

Clear aligners are a series of tight-fitting custom-made mouthpieces or orthodontic systems that are useful in correcting misaligned or crooked teeth


Augnito launches first-ever Saas Fest in India
Digitisation | November 01, 2021

Augnito launches first-ever Saas Fest in India

The company is a medical dictation solution used by medical practitioners


EMA encourages companies to submit type I variations by end- November
Policy | November 01, 2021

EMA encourages companies to submit type I variations by end- November

Marketing authorisation holders are advised to submit any type IB variations or groupings of type IBs and type IAs by 3rd December 2021 for a start of procedure in 2021


Sun Pharma's Winlevi available in the US
Drug Approval | November 01, 2021

Sun Pharma's Winlevi available in the US

It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years


3M Health Care and Thermo Fisher to increase efficiency in therapeutic manufacturing
Medical Device | October 29, 2021

3M Health Care and Thermo Fisher to increase efficiency in therapeutic manufacturing

Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers


Boehringer Ingelheim announces EMA marketing authorisation for spesolimab
Drug Approval | October 29, 2021

Boehringer Ingelheim announces EMA marketing authorisation for spesolimab

Generalized pustular psoriasis is characterized by episodes of widespread eruptions of painful, sterile pustules


Laurus Labs PAT at Rs 201.90 cr. in Q2FY21
News | October 29, 2021

Laurus Labs PAT at Rs 201.90 cr. in Q2FY21

Laurus Labs Limited has reported consolidated financial results for the period ended September 30, 2021


NH TherAguix releases new batch for AGuIX
Biotech | October 29, 2021

NH TherAguix releases new batch for AGuIX

The release of this batch will secure the supply for hospitals and cancer centres that are involved in the clinical trials managed by the company


Takeda to acquire GammaDelta Therapeutics
Biotech | October 29, 2021

Takeda to acquire GammaDelta Therapeutics

The acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging T cells for the potential treatment of solid tumours and haematological malignancies